Vital menopause therapy slashes low bone density risk by 69%

Key Points:

• New research presented at ENDO 2026 shows that hormone replacement therapy (HRT) significantly reduces the risk of low bone mineral density in postmenopausal women, lowering the chance of osteoporosis-related fractures in the spine and hip by 69%.
• Despite previous concerns about cancer risks, recent studies suggest the benefits of HRT, including improved bone health, outweigh the risks when used appropriately, especially early after menopause.
• The study analyzed 387 postmenopausal women and found that those on HRT had better bone density independent of factors like age, vitamin D levels, and smoking status.
• While HRT can relieve multiple menopausal symptoms such as hot flashes and joint pain, doctors remain cautious due to the associated cancer risks, recommending limited duration of use.
• Researchers hope these findings will encourage clinicians to reconsider HRT for bone health protection in suitable patients, potentially enhancing long-term quality of life for aging women.